LEADER 03677nam  2200613Ia 450 
001 996197696203316
005 20230607221510.0
010   $a1-281-32169-9
010   $a9786611321697
010   $a0-470-76015-X
010   $a0-470-75988-7
035   $a(CKB)1000000000415500
035   $a(EBL)351355
035   $a(OCoLC)781319108
035   $a(SSID)ssj0000224618
035   $a(PQKBManifestationID)11210505
035   $a(PQKBTitleCode)TC0000224618
035   $a(PQKBWorkID)10210796
035   $a(PQKB)10243307
035   $a(MiAaPQ)EBC351355
035   $a(Au-PeEL)EBL351355
035   $a(CaPaEBR)ebr10232799
035   $a(CaONFJC)MIL132169
035   $a(EXLCZ)991000000000415500
100   $a20000823d2001      uy         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aPortal hypertension III$b[electronic resource] $eproceedings of the Third Baverno International Consensus Workshop on Definitions, Methodology, and Therapeutic Strategies /$fedited by Roberto De Franchis
205   $a3rd ed.
210   $aOxford ;$aMalden, MA $cBlackwell Science$d2001
215   $a1 online resource (270 p.)
300   $aDescription based upon print version of record.
311   $a0-632-05918-4 
320   $aIncludes bibliographical references and index.
327   $aPortal Hypertension III; Contents; Contributors; Preface; Lecture What Have We Accomplished?; Session 1 Definition of Key Events: Let's Try Again; BAVENO III CONSENSUS STATEMENTS; Lecture Stellate Cells: Do They Have a Role in Portal Hypertension?; Session 2 Diagnosis of Portal Hypertension: How and When; BAVENO III CONSENSUS STATEMENTS; Session 3A Portal Hypertensive Gastropathy; Session 3B Gastric Varices; BAVENO III CONSENSUS STATEMENTS; Session 4 Preprimary Prophylaxis. Can (and Should) We Prevent the Formation and Growth of Varices; BAVENO III CONSENSUS STATEMENTS
327   $aLecture Antifibrotic Therapy: Future Cure for Portal Hypertension?Session 5 Primary Prophylaxis; BAVENO III CONSENSUS STATEMENTS; Session 6 Treatment of the Acute Bleeding Episode; BAVENO III CONSENSUS STATEMENTS; Session 7 Prevention of Recurrent Variceal Haemorrhage (Secondary Prophylaxis); BAVENO III CONSENSUS STATEMENTS; Session 8 Complications in the Medical Treatment of Portal Hypertension; BAVENO III CONSENSUS STATEMENTS; Lecture Quality of Randomized Clinical Trials in Portal Hypertension and Other Fields of Hepatology
327   $aSession 9 Methodology of Future Trials: Prognostic Stratification, Health-Related Quality of Life and Health EconomicsBAVENO III CONSENSUS STATEMENTS; Index
330   $aProceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies.  The participants attempted to develop consensus definitions of key events in portal hypertension and variceal bleeding, diagnostic and therapeutic issues, and the complications of therapies for portal hypertension, as well as producing updated guidelines. The lectures summarized the consensus reached in the earlier workshops, addressed two important new areas of research, and analyzed the quality of trials in portal hypertension and other fields of hepatology.
606   $aPortal hypertension$vCongresses
606   $aHypertension$vCongresses
615  0$aPortal hypertension
615  0$aHypertension
676   $a616.3/62
701   $aDe Franchis$b Roberto$0855338
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a996197696203316
996   $aPortal hypertension III$92139944
997   $aUNISA